Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Bulletin De L'Academie Nationale De Medecine
|
June 1, 1992
[Immunotherapy study in the treatment of metastatic renal cancer in the adult]
T Philip, S Negrier
La Revue Du Praticien
|
May 15, 1992
[Treatment of renal cancer in adults with interleukin 2]
S Negrier, A Mercatello, T Philip
Cancer Treatment Reviews
|
July 20, 2023
Uveal melanoma: In the era of new treatments
M Wespiser, E Neidhardt, S Negrier
Thymus
|
February 1, 1990
Fetal liver cell transplantation in scid mice
K Sanhadji, M S Negrier, J L Touraine
Pediatrie
|
January 1, 1989
[Cytokines and their receptors networks: biology and therapeutic possibilities]
M Favrot, S Negrier, V Combaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 30, 2017
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
R A Figlin, B C Leibovich, G D Stewart, et al.
The Cancer Journal From Scientific American
|
February 24, 2000
Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe
S Negrier, J Maral, M Drevon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2020
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma
L Albiges, P Barthélémy, M Gross-Goupil, et al.
British Journal of Cancer
|
March 18, 2004
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
P F Geertsen, M E Gore, S Negrier, et al.
American Journal of Clinical Oncology
|
February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary
E Voog, Y Merrouche, V Trillet-Lenoir, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Bulletin De L'Academie Nationale De Medecine
|
June 1, 1992
[Immunotherapy study in the treatment of metastatic renal cancer in the adult]
T Philip, S Negrier
La Revue Du Praticien
|
May 15, 1992
[Treatment of renal cancer in adults with interleukin 2]
S Negrier, A Mercatello, T Philip
Cancer Treatment Reviews
|
July 20, 2023
Uveal melanoma: In the era of new treatments
M Wespiser, E Neidhardt, S Negrier
Thymus
|
February 1, 1990
Fetal liver cell transplantation in scid mice
K Sanhadji, M S Negrier, J L Touraine
Pediatrie
|
January 1, 1989
[Cytokines and their receptors networks: biology and therapeutic possibilities]
M Favrot, S Negrier, V Combaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 30, 2017
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
R A Figlin, B C Leibovich, G D Stewart, et al.
The Cancer Journal From Scientific American
|
February 24, 2000
Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe
S Negrier, J Maral, M Drevon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 3, 2020
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma
L Albiges, P Barthélémy, M Gross-Goupil, et al.
British Journal of Cancer
|
March 18, 2004
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
P F Geertsen, M E Gore, S Negrier, et al.
American Journal of Clinical Oncology
|
February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary
E Voog, Y Merrouche, V Trillet-Lenoir, et al.
Page
of 5